Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind Placebo-Controlled Phase 2 Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

NCT00986440 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00986440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind Placebo-Controlled Phase 2 Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2009
Completion date
October 29, 2012
Enrollment
84 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer